These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 6160340

  • 21. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia.
    Manz M, Steinbeck G, Lüderitz B.
    Am J Cardiol; 1985 Oct 01; 56(10):593-7. PubMed ID: 4050693
    [Abstract] [Full Text] [Related]

  • 22. Termination of circus movement tachycardia utilizing an accessory atrioventricular pathway by retrograde concealed penetration of the atrioventricular node through the bundle branch system. A mechanism of tachycardia termination in Wolff-Parkinson-White syndrome.
    Ross DL, Wiener I, Farre J, Bar FW, Vanagt EJ, Wellens HJ.
    Am J Cardiol; 1981 May 01; 47(5):1173-7. PubMed ID: 7223665
    [Abstract] [Full Text] [Related]

  • 23. Concealed conduction in accessory atrioventricular pathways: an important determinant of the expression of arrhythmias in patients with Wolff-Parkinson-White syndrome.
    Klein GJ, Yee R, Sharma AD.
    Circulation; 1984 Sep 01; 70(3):402-11. PubMed ID: 6744543
    [Abstract] [Full Text] [Related]

  • 24. Effects of intravenous diltiazem administration in patients with inducible tachycardia.
    Waleffe A, Hastir F, Kulbertus HE.
    Eur Heart J; 1985 Oct 01; 6(10):882-90. PubMed ID: 4076199
    [Abstract] [Full Text] [Related]

  • 25. Electrophysiologic characteristics, electropharmacologic responses and radiofrequency ablation in patients with decremental accessory pathway.
    Chen SA, Tai CT, Chiang CE, Lee SH, Wen ZC, Chiou CW, Ueng KC, Chen YJ, Yu WC, Huang JL, Chang MS.
    J Am Coll Cardiol; 1996 Sep 01; 28(3):732-7. PubMed ID: 8772764
    [Abstract] [Full Text] [Related]

  • 26. [Sotalol in supraventricular tachycardia. Electrophysiologic measurements in Wolff-Parkinson-White syndrome and AV node re-entry tachycardia].
    Manz M, Kuhl AJ, Lüderitz B.
    Z Kardiol; 1985 Sep 01; 74(9):500-5. PubMed ID: 4060827
    [Abstract] [Full Text] [Related]

  • 27. Effect of amiodarone in the Wolff-Parkinson-White syndrome.
    Wellens HJ, Lie KI, Bär FW, Wesdorp JC, Dohmen HJ, Düren DR, Durrer D.
    Am J Cardiol; 1976 Aug 01; 38(2):189-94. PubMed ID: 952262
    [Abstract] [Full Text] [Related]

  • 28. Retrograde atrial preexcitation following premature ventricular beats during reciprocating tachycardia in the Wolff-Parkinson-White syndrome.
    Sellers TD, Gallagher JJ, Cope GD, Tonkin AM, Wallace AG.
    Eur J Cardiol; 1976 Sep 01; 4(3):283-94. PubMed ID: 964277
    [Abstract] [Full Text] [Related]

  • 29. Effects of verapamil on supraventricular tachycardia in patients with overt and concealed Wolff-Parkinson-White syndrome.
    Hamer A, Peter T, Platt M, Mandel WJ.
    Am Heart J; 1981 May 01; 101(5):600-12. PubMed ID: 7223599
    [Abstract] [Full Text] [Related]

  • 30. Effect of tiapamil in the Wolff-Parkinson-White syndrome.
    Gmeiner R, Ng CK.
    J Cardiovasc Pharmacol; 1981 May 01; 3(2):237-50. PubMed ID: 6166796
    [Abstract] [Full Text] [Related]

  • 31. Determinants of fast- and slow-pathway conduction in patients with dual atrioventricular nodal pathways.
    Wu D, Denes P, Dhingra R, Wyndham C, Rosen KM.
    Circ Res; 1975 Jun 01; 36(6):782-90. PubMed ID: 1132071
    [Abstract] [Full Text] [Related]

  • 32. Effects of flecainide on electrophysiological properties of accessory pathways in the Wolff-Parkinson-White syndrome.
    Neuss H, Buss J, Schlepper M, Berthold R, Mitrović V, Krämer A, Musial WJ.
    Eur Heart J; 1983 May 01; 4(5):347-53. PubMed ID: 6617681
    [Abstract] [Full Text] [Related]

  • 33. Effects of disopyramide on electrophysiological properties of specialized conduction system in man and on accessory atrioventricular pathway in Wolff-Parkinson-White syndrome.
    Spurrell RA, Thorburn CW, Camm J, Sowton E, Deuchar DC.
    Br Heart J; 1975 Aug 01; 37(8):861-7. PubMed ID: 53057
    [Abstract] [Full Text] [Related]

  • 34. 'Dual atrioventricular nodal pathways" in patients with Wolff-Parkinson-White syndrome.
    Pritchett EL, Prystowsky EN, Benditt DG, Gallagher JJ.
    Br Heart J; 1980 Jan 01; 43(1):7-13. PubMed ID: 7356864
    [Abstract] [Full Text] [Related]

  • 35. The electrophysiologic effects of intravenous propranolol in the Wolff-Parkinson-White syndrome.
    Barrett PA, Jordan JL, Mandel WJ, Yamaguchi I, Laks MM.
    Am Heart J; 1979 Aug 01; 98(2):213-24. PubMed ID: 453024
    [Abstract] [Full Text] [Related]

  • 36. Ethmozin. I. Effects of intravenous drug administration on paroxysmal supraventricular tachycardia in the ventricular preexcitation syndrome.
    Chazov EI, Shugushev KK, Rosenshtraukh LV.
    Am Heart J; 1984 Sep 01; 108(3 Pt 1):475-82. PubMed ID: 6382988
    [Abstract] [Full Text] [Related]

  • 37. Alfentanil-midazolam anaesthesia has no electrophysiological effects upon the normal conduction system or accessory pathways in patients with Wolff-Parkinson-White syndrome.
    Sharpe MD, Dobkowski WB, Murkin JM, Klein G, Guiraudon G, Yee R.
    Can J Anaesth; 1992 Oct 01; 39(8):816-21. PubMed ID: 1288908
    [Abstract] [Full Text] [Related]

  • 38. Acute effects of simvastatin to terminate fast reentrant tachycardia through increasing wavelength of atrioventricular nodal reentrant tachycardia circuit.
    Khori V, Alizadeh AM, Moheimani HR, Zahedi M, Aminolsharieh Najafi S, Shakiba D, Nayebpour M.
    Fundam Clin Pharmacol; 2015 Feb 01; 29(1):41-53. PubMed ID: 24990322
    [Abstract] [Full Text] [Related]

  • 39. Effects of intravenous sotalol in patients with atrioventricular accessory pathways.
    Touboul P, Atallah G, Kirkorian G, Lavaud P, Mathieu MP, Dellinger A.
    Am Heart J; 1987 Sep 01; 114(3):545-50. PubMed ID: 3630895
    [Abstract] [Full Text] [Related]

  • 40. A possible mechanism of reciprocating tachycardia initiated by critical shortening of the atrial cycle length in concealed Wolff-Parkinson-White syndrome. Report of a case.
    Ohe T, Ejiri N, Kamakura S, Matsuhisa M, Hirata Y, Shimomura K.
    Jpn Heart J; 1981 Jan 01; 22(1):135-42. PubMed ID: 7218523
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.